Chargement en cours...
Management of bipolar I depression: clinical utility of lurasidone
Lurasidone is a benzisothiazol derivative second-generation antipsychotic. It has been approved in the United States and Europe for treatment of acute schizophrenia and bipolar depression. In type I bipolar subjects, treatment with lurasidone monotherapy of adjunctive therapy to lithium or valproic...
Enregistré dans:
| Publié dans: | Ther Clin Risk Manag |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4293929/ https://ncbi.nlm.nih.gov/pubmed/25609973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S57695 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|